ReNetx Bio
Andrew Blight received his PhD from the University of Bristol in the UK and completed postdoctoral fellowships in the U.S. at NYU and Germany at Max Planck Institute. He subsequently held faculty positions at New York University Medical Center (1980-1987), Purdue University (1987-1992) and the University of North Carolina where he was Professor and Director of the Neurosurgery Research Laboratory from 1992-1998. He joined Acorda Therapeutics, Inc. in 1998 and was Chief Scientific Officer from 2004 to 2017.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
ReNetx Bio
1 followers
Changing lives through the REstoration of neural NETworks. ReNetx Bio's mission is to provide first-in-class therapeutics to treat injury/damage to the central nervous system (CNS) in conditions such as spinal cord injury (SCI), stroke, and glaucoma.